Seeking AlphaThu, 30 Apr 2026 18:22:44 GMTNuvalent: A Precision Oncology Platform With Two Near-Term Shots On GoalNUVL+0.87%
Zacks Investment ResearchFri, 27 Feb 2026 15:55:32 GMTDoes Nuvalent (NUVL) Have the Potential to Rally 37.26% as Wall Street Analysts Expect?NUVL+0.87%